KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bristol Myers Squibb (BMY) Gains from Investment Securities (2016 - 2025)

Historic Gains from Investment Securities for Bristol Myers Squibb (BMY) over the last 17 years, with Q4 2025 value amounting to $15.0 million.

  • Bristol Myers Squibb's Gains from Investment Securities fell 4827.59% to $15.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $341.0 million, marking a year-over-year increase of 558333.33%. This contributed to the annual value of $351.0 million for FY2025, which is 47340.43% up from last year.
  • Latest data reveals that Bristol Myers Squibb reported Gains from Investment Securities of $15.0 million as of Q4 2025, which was down 4827.59% from $336.0 million recorded in Q2 2025.
  • Bristol Myers Squibb's 5-year Gains from Investment Securities high stood at $336.0 million for Q2 2025, and its period low was -$510.0 million during Q1 2021.
  • Its 5-year average for Gains from Investment Securities is -$61.2 million, with a median of -$23.0 million in 2024.
  • Examining YoY changes over the last 5 years, Bristol Myers Squibb's Gains from Investment Securities showed a top increase of 17250.0% in 2024 and a maximum decrease of 47500.0% in 2024.
  • Bristol Myers Squibb's Gains from Investment Securities (Quarter) stood at -$32.0 million in 2021, then plummeted by 37.5% to -$44.0 million in 2022, then rose by 9.09% to -$40.0 million in 2023, then soared by 172.5% to $29.0 million in 2024, then tumbled by 48.28% to $15.0 million in 2025.
  • Its Gains from Investment Securities stands at $15.0 million for Q4 2025, versus $336.0 million for Q2 2025 and -$10.0 million for Q1 2025.